Canopy Growth Shares Why It Got into U.S. CBD Beverage Game

Spread the love

<![CDATA[

Offering a different take on beverages such as beer, coffee and lemonade, brands are serving cannabis consumers with tetrahydrocannabinol (THC) and cannabidiol (CBD) in drinkable form.

One of Canada’s licensed producers (LPs), publicly traded Canopy Growth, which has infused and sold beverages in Canada over the past year, is now bringing its beverages below the border to the U.S. It’s starting with flavored cans of sparkling water with 20 milligrams of CBD that it’s marketing under the Quatreau brand.

“The North American market potential for CBD-infused beverages is extremely promising, and with the continued growth the industry is seeing, we know it has the potential to really disrupt other traditional beverage formats, from sparkling water and soda to beer, wine and spirits,” said Tara Rozalowsky, Canopy’s vice president of beverages and edibles.

RELATED: THC-Infused Tonics Find Their Place in Cannabis Beverage Market in 2020

Rozalowsky said Canopy sees the opportunity to enter the U.S. CBD beverage space due to its large size, experience manufacturing hemp products, ability to scale, and understanding of industry regulations.

“Since the launch of Canopy’s first THC-infused beverage in Canada in early 2020, we held the No. 1 share position at 36.1% for overall sales in 2020,” Rozalowsky said. “Our Tweed, Deep Space and Houseplant THC-infused beverages were 3 of the top 5 SKUs [stock keeping units] in calendar Q4, and since the launch of Quatreau, our first CBD-infused beverage in Canada, it has maintained the No. 1 position in the CBD-infused beverage category overall.”

Rozalowsky said Canopy sources its hemp from farmers in New York’s Southern Tier, Oregon and California, and that the company “will continue to work with those communities and select wholesalers in the market for future needs.”

Canopy and Constellation Brands, the company that has a roughly 39% stake in Canopy and owns beverage brands such as Corona and Modelo, looked at consumer insights to determine market potential, Rozalowsky said. “[W]e identified top key differentiators we could own: The highest CBD potency at a lower price point, zero sugar and low calories made with pure CBD isolate,” she said.

Carbonated water and natural flavors are some of the other components that Rozalowsky said make Quatreau “a refreshing and effervescent zero-sugar drink with a consistently potent effect.”

Quatreau aims to redefine consumers’ relationship with energy and productivity by replacing the stimulants, sugar, and artificial ingredients found in most sodas, coffees, and energy drinks with a clean, balanced, and sessionable alternative,” Rozalowsky said.

Canopy’s launch of CBD beverages in the U.S. follows its announcement of plans to manufacture and sell THC beverages in U.S. state-legal markets. “Initially, as a cannabis company, our focus was on THC beverages in Canada, which we’ve rolled out very successfully in that market,” Rozalowsky said. “We plan to begin bringing our THC-infused beverages into the U.S. this summer through our partnership with Acreage.”

Canopy can become a leader in the U.S. CBD beverage category, Rozalowsky said, citing 2020 BDSA data that states that the space’s top three brands represent about 12% of market share. The total U.S. retail market is expected to grow to $495 million by 2022, she said, again citing BDSA.

“The CBD-infused beverage category is one of the fastest-growing and high-potential sectors in our industry, and a key part of our strategy for capturing U.S. market share,” Rozalowsky said. “As a company, we are actively investing budget and resources into innovation with the development of a best-in-class innovation department whose sole focus is to create the future of cannabis to improve the lives of consumers.”

 

]]>
Source: One

Schaka

Related Posts

A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional beta-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants

Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland

Poison Control Centers Nationally Report Rise in Calls Amid Delta-8 Craze

Poison Control Centers Nationally Report Rise in Calls Amid Delta-8 Craze

Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits

Signez la pétition !!!

 

845 signatures

Pétition ASBL Cannabis Belgique

Pourquoi une pétition ?

Nous sommes des personnes qui en avons assez de devoir aller dans la rue et avoir affaire à des réseaux criminels sans savoir où cela va nous conduire par après.

Nous sommes des personnes ayant des maladies, qui pour certaines sont rares, et utilisant pour médication le cannabis sous diverses formes (CBD,THC,THCv,CBDa,,,) sous l'accord de notre médecin.

Nous sommes des personnes responsables et honnêtes qui avons une vie épanouie et sans problèmes de vie ou sociaux.

Nous avons également une passion pour la plante de cannabis en elle-même et la cultiver est notre bonheur. De plus, nous pouvons nous soigner avec notre médication sans avoir peur des produits ou autres additifs contenus dans une plante que l'on peut trouver autre part.

Nous souhaitons pouvoir avoir notre médicament dans les normes de la santé publique, car un cannabis sain aide à réduire les frais de santé parfois conséquents pour la collectivité et le malade lui-même.

Nous sommes également des personnes responsables avec un rôle dans la société qui en avons assez d’être considérés comme des « hippies ou autres drogués », nous avons juste choisi notre médication et celle-ci a apporté les preuves de son efficacité dans le monde.

Nous connaissons déjà les produits dérivés comme le CBD et le THC que nous maîtrisons pour nous aider dans notre maladie « Je précise que nous ne sommes pas médecin et que nous nous basons sur 20 ans d’expérience médicale du cannabis des membres de notre ASBL et l'avis du médecin de famille ».

Nous désirons simplement ne plus nous cacher, et pouvoir aider les autres personnes le souhaitant.

Nous somme soucieux des ados et de la prévention à leur égard. Effectivement, nous sommes les acteurs parfaits pour répondre aux questions qu’ils se posent vu notre expérience cannabique et, de plus, nous pourrons leur expliquer les risques qu’ils encourent en achetant du cannabis dans la rue.

Le projet complet peut être demandé via mail " info@mcb.care " et sur le site internet : " http://mcb.care "

@ASBL McB

**votre signature**

Partagez avec vos amis

Articles récents

Catégories